Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher M. Moxham
Christopher M. Moxham
Eli Lilly and Company
Biology
Classical pharmacology
Biotechnology
Suramin binding
Suramin
3
Papers
211
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
2012
Journal of Medicinal Chemistry
Jonathan A. Lee
Mark T. Uhlik
Christopher M. Moxham
Dirk Tomandl
Daniel Jon Sall
Show All
Source
Cite
Save
Citations (155)
Open Innovation for Phenotypic Drug Discovery: The PD2 Assay Panel
2011
Journal of Biomolecular Screening
Jonathan A. Lee
Shaoyou Chu
Francis S. Willard
Karen L. Cox
Rachelle J. Sells Galvin
Robert B. Peery
Sarah Oliver
Jennifer Oler
Tamika DeShea Meredith
Steven A. Heidler
Wendy H. Gough
Saba Husain
Alan David Palkowitz
Christopher M. Moxham
Show All
Source
Cite
Save
Citations (48)
Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation
2005
Bone
Ajit Regmi
Tina Fuson
Xuhao Yang
Joanne Kays
Christopher M. Moxham
Edward R. Zartler
Srinivasan Chandrashekhar
Rachelle J. Sells Galvin
Show All
Source
Cite
Save
Citations (8)
1